Image
Back to top
Prof Thrasyvoulos Tzellos
Dermatologist
Professor Thrasyvoulos Tzellos is Dermatologist at the Department of Dermatology, NLSH Bodø, Norway, and Associate Professor at Institute of Clinical Medicine, University of Tromsø, Norway.
Professor Tzellos received his medical degree from the Aristotle University of Thessaloniki, Greece, moving on to complete an MSc in Clinical Research and Epidemiology and a PhD from the same institution. He has also completed several postgraduate courses on educational techniques, epidemiology and clinical pharmacology in healthcare.
He has published over 100 peer-reviewed articles and his current research expertise lies in the field of evidence-based medicine, clinical trials, meta-analyses, case-control studies, cohort studies and large-scale epidemiological studies. He is actively involved in clinical research on hidradenitis suppurativa and is a founding member of the European Hidradenitis Suppurativa Foundation (EHSF).
0 resources
You are currently seeing only Dermatology content
File672 KB size
The first part of the workshop highlights the role of shared decision-making for personalised care in women of childbearing age affected by psoriasis and PsA....
File633 KB size
The workshop highlights the challenges and treatment considerations with psoriasis and HS that go beyond the skin. Underlying disease pathophysiology, including...
Video51 min watch
The speakers discuss the continued unmet needs of patients with inflammatory diseases of skin and joints in terms of treatment outcomes and health-related...
Video59 min watch
This session reviews the chronic inflammation and pathophysiology of HS, highlighting the association between patients with inflammatory arthritis and HS. The...
Video61 min watch
This session focuses on the pathobiological relationship between psoriasis and psoriatic arthritis (PsA), how transition from psoriasis to PsA occurs, as well as...
Video68 min watch
In this session, our speakers explore the inflammatory pathways in immune-mediated inflammatory disease in the context of the evolving treatment considerations...